Home

overview

Join us for an interactive and engaging symposium that takes a deep dive into the latest clinical evidence for novel therapies targeting IDH-mutant gliomas and how this can be translated into clinical practice, including expert perspectives on providing individualized, comprehensive care that maximizes long-term outcomes for your patients.

Not an official event of the 2024 ASCO® Annual Meeting. Not sponsored, endorsed, or accredited by ASCO®, Association for Clinical Oncology, or Conquer Cancer® the ASCO Foundation.

faculty

CHAIR

Patrick Y. Wen, MD

Director

Center for Neuro-Oncology

Dana-Farber Cancer Institute

Chief, Division of Neuro-Oncology

Department of Neurology

Brigham and Women’s Hospital

Professor of Neurology

Harvard Medical School

Boston, Massachusetts, United States

PANELIST

Macarena de la Fuente, MD

Chief

Neuro-Oncology Division

Sylvester Comprehensive Cancer Center

University of Miami

Miami, Florida, United States

PANELIST

Matthias Preusser, MD

Professor of Medical Oncology

Division of Oncology

Medical University of Vienna

Vienna, Austria

PANELIST

Florien Boele, PhD

Associate Professor of Medical Psychology

Patient Centered Outcomes Research (PCOR)

Leeds Institute of Medical Research

Leeds Cancer Centre

Leeds, United Kingdom

AGENDA

6:15 pm

Registration and Meal

6:45 pm

Welcome and Introduction

6:55 pm

Beyond Diagnosis: Living Well with Glioma and Maximizing Quality of Life

7:10 pm

Deep Dive Into Novel Strategies for IDH-Mutant Gliomas: IDH Inhibitors

7:20 pm

On the Horizon: Innovative Approaches in Early Development

7:30 pm

Translating Clinical Insights Into Everyday Practice

7:50 pm

Patient-Centered Pathways: Building Success Throughout the Care Continuum

8:05 pm

Audience Q&A and Concluding Remarks

8:15 pm

Adjourn

GOAL STATEMENT

The goal of this activity is for learners to be better able to understand the role of novel systemic therapies in improving outcomes for patients with IDH-mutant glioma and recognize the factors impacting their quality of life and overall well-being.

TARGET AUDIENCE

This educational activity is intended for a global audience of medical oncologists, neuro-oncologists, radiation oncologists, neurosurgeons, pathologists, and other members of the care team involved in the management of brain tumors.

LEARNING OBJECTIVES

Upon completion of this activity, participants will:

Have increased knowledge regarding the

Latest clinical data evaluating novel and emerging therapies targeting IDH mutations in patients with gliomas
Identification of patients with IDH-mutant glioma who may benefit from novel targeted therapy

Demonstrate greater confidence in their ability to

Understand the implications of the latest evidence for novel targeted therapy for IDH-mutant glioma

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses

Awarded up to 1.50 contact hour(s) of nursing continuing professional development for RNs and APNs.

For Pharmacists

Medscape designates this continuing education activity for 1.50 contact hour(s) (0.150 CEUs) (Universal Activity Number: JA0007105-0000-24-142-L01-P).

CME/CNE/CPE

overview

Not an official event of the 2024 ASCO® Annual Meeting. Not sponsored, endorsed, or accredited by ASCO®, Association for Clinical Oncology, or Conquer Cancer® the ASCO Foundation.

faculty

AGENDA

Registration and Meal

Welcome and Introduction

Beyond Diagnosis: Living Well with Glioma and Maximizing Quality of Life

Deep Dive Into Novel Strategies for IDH-Mutant Gliomas: IDH Inhibitors

On the Horizon: Innovative Approaches in Early Development

Translating Clinical Insights Into Everyday Practice

Patient-Centered Pathways: Building Success Throughout the Care Continuum

Audience Q&A and Concluding Remarks

Adjourn

LOCATION

Hilton Chicago

GOAL STATEMENT

TARGET AUDIENCE

LEARNING OBJECTIVES

ACCREDITATION STATEMENT

For Physicians

For Nurses

For Pharmacists